BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34171181)

  • 1. Identification and characterization of effusion tumor cells (ETCs) from remnant pleural effusion specimens.
    Zhu Y; Allard GM; Ericson NG; George TC; Kunder CA; Lowe AC
    Cancer Cytopathol; 2021 Nov; 129(11):893-906. PubMed ID: 34171181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of effusion tumor cells under different storage and processing conditions.
    Libert DM; Zhu Y; Wang A; Allard GM; Cheng-Yi Lowe A
    Cancer Cytopathol; 2024 May; 132(5):297-308. PubMed ID: 38373107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
    Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
    Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
    Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
    Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
    Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
    J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
    Assi Z; Caruso JL; Herndon J; Patz EF
    Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
    Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
    BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the detection of the homozygous deletion of P16 gene in malignant pleural effusion.
    Gui S; Liu H; Zhang L; Zuo L; Zhou Q; Fei G; Wang Y
    Intern Med; 2007; 46(15):1161-6. PubMed ID: 17675763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Cappellesso R; Nicolè L; Caroccia B; Guzzardo V; Ventura L; Fassan M; Fassina A
    Cancer Cytopathol; 2016 Jan; 124(1):28-37. PubMed ID: 26765063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?
    Jha S; Sethy M; Sharma G; Adhya AK
    Diagn Cytopathol; 2022 Jun; 50(6):284-288. PubMed ID: 35362266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.
    Elmas H; Biancosino C; Önal B; Schmitt F; Buyucek S; Nordholt G; Sauter G; Welker L
    Adv Exp Med Biol; 2022; 1374():51-62. PubMed ID: 35147931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
    Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
    PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
    Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
    BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome analysis in pleural effusions. Efficiency of this method in the differential diagnosis of pleural effusions.
    Metintaş M; Ozdemir N; Solak M; Artan S; Ozdemir M; Başaran N; Ekici M; Erginel S
    Respiration; 1994; 61(6):330-5. PubMed ID: 7824813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.